Odor identification deficit of the parkinsonism‐dementia complex of Guam

  title={Odor identification deficit of the parkinsonism‐dementia complex of Guam},
  author={Richard L. Doty and Daniel P. Perl and John C.H. Steele and K-M Chen and Jace D Pierce and Pamela Reyes and Leonard T. Kurland},
  pages={77 - 80}
Olfactory dysfunction is among the first signs of Alzheimer's disease (AD), idiopathic Parkinson's disease (PD), and the parkinsonism-dementia complex (PDC) of Guam. We have recently demonstrated that the odor identification and detection deficits of patients with PD are equivalent to those of patients with mild AD when subtle differences in cognitive function are statistically controlled for by analysis of covariance. In contrast, patients with progressive supranuclear palsy (PSP) and patients… 

Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia

Marked olfactory deficits are common to all four Guamanian neurodegenerative syndromes, and suggest the possibility of similar central neuropathologic substrates.

Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease

It is demonstrated that patients with PSP and PD differ markedly in their ability to smell and suggest that olfactory testing may be useful in their differential diagnosis.

Chemosensory dysfunction in neurodegenerative diseases.

Olfactory function in atypical parkinsonian syndromes

Preserved or mildly impaired olfactory function in a parkinsonian patient is more likely to be related to atypical parkinsonism such as MSA, PSP or CBD, whereas markedly reduced olfaction is more suggestive of IPD.

Olfaction in neurodegenerative disorder

  • C. Hawkes
  • Medicine, Biology
    Movement disorders : official journal of the Movement Disorder Society
  • 2003
In this review of PD, parkinsonian syndromes, essential tremor, AD, motor neurone disease (MND) and Huntington's chorea, olfactory dysfunction is frequent and often severe in PD and AD.

Olfaction in Parkinson's disease and related disorders

  • R. Doty
  • Biology, Psychology
    Neurobiology of Disease
  • 2012

Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.

The findings indicate that the olfactory dysfunction of early stage PD is robust, typically of the same general magnitude on both sides of the nose, and uninfluenced by anti-Parkinsonian medications.

Olfactory dysfunction in Parkinson disease

  • R. Doty
  • Biology, Psychology
    Nature Reviews Neurology
  • 2012
Neuroanatomical findings suggest that deficits in cholinergic, noradrenergic and serotonergic function may contribute to the olfactory loss in Parkinson disease.